{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obstetrical and Gynecological Survey - Vol. 74, No. 8 ((Non-Physician Credit))

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. CME Article Title: Review of Recent Physical Activity Guidelines During Pregnancy to Facilitate Advice by Health Care Providers -- Describe the most recent recommendations for physical activity during pregnancy; explain the relative and absolute contraindications to physical activity during pregnancy; and identify the warning signs for pregnant women to stop physical activity.
  2. CME Article Title: Immune Thrombocytopenic Purpura in Pregnancy -- Describe thrombocytopenia in pregnancy and identify common manifestations; select appropriate tests for evaluation of thrombocytopenia; and explain treatment options for management of ITP during pregnancy and delivery considerations for women with this condition.
  3. CME Article Title: Congenital Heart Disease: Prenatal Diagnosis and Genetic Associations -- Distinguish the appropriate genetic screening and testing when congenital cardiac defects are diagnosed; assess associated risks of genetic abnormality with a diagnosed congenital cardiac defect; refer patients to genetic counselors for appropriate indication(s); describe the risks, benefits, and limitations of antenatal genetic testing and educate patient regarding these risks, benefits, and limitations; and identify indications for screening fetal echocardiography.

Disclosures

All authors, faculty and staff in a position to control the content of this CME activity, and their spouses/life partners (if any), have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations relevant to this CME activity.

Off-Label Usage

The authors have disclosed that the U.S. Food and Drug Administration has not approved the use of eltrombopag or romiplostim for the treatment of immune thrombocytopenia purpura in pregnancy as discussed in this article. Please consult the products' labeling for approved information.

Price: $30.00

Credits:

  • ACCME 3.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Other Health Professional
Test Code: OGSN0819
Published: August 2019
Expires: 1/1/2026
Sources: Obstetrical & Gynecological Survey
Required Passing Score: 9/12 (75%)
Authors: Kelly R. Evenson, PhD, MS, FACSM, Michelle F. Mottola, PhD, FACSM, and Raul Artal, MD, FACSM, FACOG; Amanda M. Baucom, BS, Jeffrey A. Kuller, MD, and Sarah Dotters-Katz, MD, MMHPE; Maeve K. Hopkins, MD, MA, Lorraine Dugoff, MD, and Jeffrey A. Kuller, MD
Categories: Gynecological , Obstetrical
Specialties: Gynecology, OB/GYN
Topics: Congenital Heart Disease , Pregnancy , Thrombocytopenia